The clinical decision support developer and supplier of clinical decision
support systems last week provided an FY April 2021 trading update.
DXS has been able to achieve a similar profit to the year ending 2020
with turnover marginally improved for the same period. This was due
to a slight increase in existing sales from both the NHS and the
Pharmaceutical industry and initial revenue for the Hypertension
program. Last financial year to 30 April 2020, turnover was £3.28m and
net profit w ....
